Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate Vaccine

Background. The group A meningococcal vaccine (PsA-TT) clinical development plan included clinical trials in India and in the West African region between 2005 and 2013. During this period, the Meningitis Vaccine Project (MVP) accumulated substantial experience in the ethical conduct of research to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Martellet, Lionel, Sow, Samba O., Diallo, Aldiouma, Hodgson, Abraham, Kampmann, Beate, Hirve, Siddhivinayak, Tapia, Milagritos, Haidara, Fadima Cheick, Ndiaye, Assane, Diarra, Bou, Ansah, Patrick Odum, Akinsola, Adebayo, Idoko, Olubukola T., Adegbola, Richard A., Bavdekar, Ashish, Juvekar, Sanjay, Viviani, Simonetta, Enwere, Godwin C., Marchetti, Elisa, Chaumont, Julie, Makadi, Marie-Francoise, Pallardy, Flore, Kulkarni, Prasad S., Preziosi, Marie-Pierre, LaForce, F. Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639500/
https://www.ncbi.nlm.nih.gov/pubmed/26553670
http://dx.doi.org/10.1093/cid/civ598

Ejemplares similares

Ejemplares similares